Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Cardioprotective effects of carvedilol metabolite are less potent than those of the parent drug

Nov. 3, 1998

Continuing efforts at Parke-Davis result in structurally novel functional ETA receptor antagonist

Nov. 2, 1998

New K+ channel blockers for arrhythmias, ulcers and related disorders

Nov. 2, 1998

How does bradykinin receptor blockade affect responses to ACE inhibition?

Oct. 30, 1998

UT-15 administered successfully to patients with impaired liver function

Oct. 30, 1998

Selective ETA or mixed ETA/ETB antagonist for CHF?

Oct. 29, 1998

Complement inhibitor TP10 improves outcome in pig model of bypass surgery

Oct. 28, 1998

Purepac's generic diltiazem capsules tentatively approved by FDA

Oct. 28, 1998

Glycolipid derivative shows cardioprotective activity in animal models

Oct. 26, 1998

New Na+/H+ exchange inhibitors in development at HMR

Oct. 26, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...